- Trials with a EudraCT protocol (186)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
		
	   		
	   		    
                    
                   	
                   	    186 result(s) found for: Implant failure.
                    
                
			
   			
		
		Displaying page 1 of 10.
	
	
	| EudraCT Number: 2013-003940-21 | Sponsor Protocol Number: 46361 | Start Date*: 2014-03-20 | 
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Systemic antibiotic therapy (amoxicillin plus metronidazole) as an adjunct to surgical treatment of peri-implantitis; a single blind randomized controlled study | ||
| Medical condition: peri-implantitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002168-42 | Sponsor Protocol Number: 20052017 | Start Date*: 2018-12-18 | 
| Sponsor Name:Iciar Arteagoitia Calvo | ||
| Full Title: Efficacy of clindamycin in preventing infection and failure after dental implant placement: a placebo-controlled randomized clinical trial. | ||
| Medical condition: Healthy volunteers (Postoperative infections and dental implant failures) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-000294-33 | Sponsor Protocol Number: LX201-02 | Start Date*: 2007-07-27 | |||||||||||
| Sponsor Name:Lux Biosciences, Inc. | |||||||||||||
| Full Title: A MULTI-CENTER, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP, DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF LX201 IMPLANTATION FOR THE PREVENTION OF CORNEAL ALLOGRAFT REJECTION EPISODES... | |||||||||||||
| Medical condition: Patient after penetrating keratoplasty who have experienced one or more rejection episodes | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-000295-16 | Sponsor Protocol Number: LX201-01 | Start Date*: 2007-07-27 | |||||||||||
| Sponsor Name:Lux Biosciences, Inc. | |||||||||||||
| Full Title: A MULTI-CENTER, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF LX201 FOR PREVENTION OF CORNEAL ALLOGRAFT REJECTION EPISODES AND GRAFT FAILURE... | |||||||||||||
| Medical condition: Patient after penetrating keratoplasty who are at increased immunological risk for corneal allograft rejection episodes and/or graft failure | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-002118-37 | Sponsor Protocol Number: HTAJ-TRANEX-2019-01 | Start Date*: 2021-06-17 | 
| Sponsor Name:Rafael Blancas-Gómez Casero | ||
| Full Title: MULTICENTER, DOUBLE BLIND CLINICAL TRIAL TO EVALUATE THE ANTIHEMORRAGIC EFFECT OF THE TOPICAL TRANEXAMIC ACID DURING PACEMAKER IN ANTICOAGULATED PATIENTS | ||
| Medical condition: Pacemaker implant for anticoagulated patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-000885-39 | Sponsor Protocol Number: 02289 | Start Date*: 2021-01-12 | |||||||||||
| Sponsor Name:Universitätsmedizin Göttingen | |||||||||||||
| Full Title: Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure | |||||||||||||
| Medical condition: Heart Failure | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-024328-53 | Sponsor Protocol Number: HULPOFT-2010-01 | Start Date*: 2012-05-14 | 
| Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario La Paz | ||
| Full Title: Phase IIa clinical trial to determine the feasibility and safety of using autologous expanded stem cell (ASC) from fat in the treatment of keratopathy associated with bilateral limbic insufficiency | ||
| Medical condition: Keratopathy associated with bilateral limbic insufficiency. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-001357-26 | Sponsor Protocol Number: 13-036 | Start Date*: 2014-08-04 | ||||||||||||||||
| Sponsor Name:Clinical Trial Center Aachen | ||||||||||||||||||
| Full Title: HIGH DOSE SUPPLEMENTATION OF SELENIUM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) IMPLANT SURGERY – A DOUBLE BLIND RANDOMISED CONTROLLED TRIAL | ||||||||||||||||||
| Medical condition: Selenium is a key component of a number of selenoproteins which protect against oxidative stress and is well recognised for its prominent role in immune defence. Selenoproteins have the potential t... | ||||||||||||||||||
| 
 | ||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2007-006606-16 | Sponsor Protocol Number: F003MN0307_1 | Start Date*: 2008-07-11 | |||||||||||
| Sponsor Name:University of Wuerzburg | |||||||||||||
| Full Title: The Effects of Paricalcitol capsules on Inflammation (CRP levels) and Calcification regulation (fetuin-A levels) in CKD stage 5D patients | |||||||||||||
| Medical condition: Chronic kidney disease | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2021-000995-13 | Sponsor Protocol Number: DECODE-CKD | Start Date*: 2022-01-26 | |||||||||||
| Sponsor Name:Department of Cardiology, Herlev and Gentofte hospital | |||||||||||||
| Full Title: A 6-Month, Randomized, Double-Blind Study to Evaluate the Effect of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease (DECODE-CKD) | |||||||||||||
| Medical condition: Chronic kidney disease | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2011-002219-28 | Sponsor Protocol Number: 2011-002219-28 | Start Date*: 2011-12-12 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | |||||||||||||
| Full Title: Effect of pharmacological prophylaxis with low molecular weight heparin on implantation in women undergoing assisted reproductive procedures to prevent implant failure: a prospective randomized study. | |||||||||||||
| Medical condition: Inability to conceive after a year of sexual relations free from any system of contraception | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-016970-33 | Sponsor Protocol Number: MACI00809 | Start Date*: 2011-03-17 | ||||||||||||||||
| Sponsor Name:Genzyme Europe BV | ||||||||||||||||||
| Full Title: An Extension Protocol for Participants of Genzyme-Sponsored Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study of Matrix-Induced Autologous Chondrocyte Implantation (MACI® impl... | ||||||||||||||||||
| Medical condition: Symptomatic Articular Cartilage Defects of the Femoral Condyle including the Trochlea. Osteochondritis dissecans lesions that do not require a bone graft. | ||||||||||||||||||
| 
 | ||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Completed) CZ (Completed) GB (Completed) SE (Completed) PL (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2016-002673-35 | Sponsor Protocol Number: Fos.06/2016 | Start Date*: 2017-03-29 | 
| Sponsor Name:PRO-IMPLANT Foundation | ||
| Full Title: Efficacy and safety of intravenous fosfomycin in prosthetic joint infection (PJI) caused by staphylococci, streptococci, enterococci and gram-negative bacilli, including mixed infections and cultur... | ||
| Medical condition: Prosthetic joint infection of knee, hip or shoulder | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-005394-66 | Sponsor Protocol Number: ESR-20-21070 | Start Date*: 2022-02-21 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA SENESE | |||||||||||||
| Full Title: Effects of Dapagliflozin on cardiac deformation and clinical outcomes in heart failure with reduced and mildly reduced ejection fraction | |||||||||||||
| Medical condition: heart failure with left ventricular ejection fraction <50% | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-000726-10 | Sponsor Protocol Number: ADAPT | Start Date*: 2021-06-23 | |||||||||||
| Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI | |||||||||||||
| Full Title: Evaluating the short-term renal and systemic effects of Dapagliflozin in non-diabetic patients with stage IV CKD at risk of ESKD because of severe renal insufficiency and persistent proteinuria: A ... | |||||||||||||
| Medical condition: Non-diabetic stage IV Chronic Kidney Disease (CKD) | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-000490-40 | Sponsor Protocol Number: S320.2.003 | Start Date*: 2007-06-20 | |||||||||||
| Sponsor Name:Solvay Pharmaceuticals GmbH | |||||||||||||
| Full Title: Randomised, Double-Blind, Placebo-Controlled, Multi-Center, Sequential Cohort Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects with C... | |||||||||||||
| Medical condition: Renal Function in Subjects with Congestive Heart Failure and Impaired Renal Function who are on Chronic Furosemide Treatment | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) CZ (Prematurely Ended) ES (Ongoing) DE (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-004625-42 | Sponsor Protocol Number: KardioPII | Start Date*: 2009-01-09 | 
| Sponsor Name:Asklepios Kliniken Hamburg GmbH | ||
| Full Title: Percutaneous Intramyocardial Cell Therapy After Acute Myocardial Infarction using Bone Marrow Mononuclear Cells | ||
| Medical condition: Acute myocardial infarction (LVEF<45%) ICD10: I21.9 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-003481-18 | Sponsor Protocol Number: CART.III. | Start Date*: 2008-11-17 | 
| Sponsor Name:TBF | ||
| Full Title: PHASE III PROTOCOL COMPARING A MICROFRACTURE TREATMENT TO A CARTIPATCH® CHONDROCYTE GRAFT TREATMENT IN FEMORAL CONDYLE LESIONS | ||
| Medical condition: Femoral condyles single lesion from trauma or osteochondritis dissequans with invalidant signs | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-007055-13 | Sponsor Protocol Number: CTU 043C | Start Date*: 2009-07-17 | 
| Sponsor Name:RIEMSER Arzneimittel AG | ||
| Full Title: DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PROSPECTIVE MULTI-CENTRE PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF METHANTHELINIUM BROMIDE (VAGANTIN®) IN THE TREATMENT OF FOCAL PALMAR-AXILL... | ||
| Medical condition: Treatment of patients with axillary and palmar hyperhidrosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-012928-89 | Sponsor Protocol Number: 1.1042009 | Start Date*: 2009-10-21 | |||||||||||
| Sponsor Name:South Tees NHS Trust | |||||||||||||
| Full Title: Intrathecal injection of a single dose of Ziconotide (Prialt®) to evaluate the option of continuous administration via implanted pump. A Pilot Study | |||||||||||||
| Medical condition: Severe, Chronic pain in patients who require intrathecal analgesia | |||||||||||||
| 
 | |||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
			Subscribe to this Search
To subscribe to the RSS feed for this search click here .
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		
			
To subscribe to the RSS feed for this search click here
 .
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
 Query did not match any studies.
    	Query did not match any studies.
     
				
